American Cyanamid Company

Thomas G Miner

Robert G Shepherd

Seymour Bernstein

Jay Donald Albright

Robert E Schaub

Francis M Callahan

Cation salts of substituted phenyl-1-thio(poly-O-sulfo)-.alpha.(or .beta.)-D-glucopyranoside, useful as modulators of the complement system, the intermediates thereof and the process of making such intermediates and end products.

Substituted phenyl-1-thio(poly-O-sulfo)-.alpha.(or

Poly-cation salts of 4-O-polyhexaose-thio-arylene sulfate derivatives, useful as modulators of the complement system, the intermediates thereof and the process of making such intermediates and products.

Poly-cation salt of 4-O-polyhexaose-thio-arylene sulfates

Poly-cation salts of 4-O-polyhexaose-thio-alkylene sulfate derivatives, useful as modulators of the complement system, the intermediates thereof and the process of making such intermediates and products.

Poly-cation salts of 4-O-poly-hexaose-thio-alkylene sulfate derivatives

Poly-cation salts of bis-(or tris-) [polyhexaose-thio (or sulfinyl, or sulfonyl)]-arylene sulfate derivatives, useful as modulators of the complement system, the intermediates thereof and the process of making such intermediates and end products.

Modulators of the complement system

Bis-[.beta.-D-glucopyranosyl-1-thio (or sulfinyl or sulfonyl)]-arylene sulfate derivatives, the cation salts thereof, useful as modulators of the complement system, the intermediates thereof and the process for the preparation of such intermediates and end products.

Novel para-[aryl(alkyl or alkenyl)amino]benzoic acids, esters, pharmaceutically acceptable salts and pharmaceutical compositions thereof and a method of lowering serum lipid levels in mammals therewith.

Antilipidemicpara-[aryl(alkyl or alkenyl)amino]benzoic acid derivatives

This disclosure describes pharmaceutical compositions having hypolipidemic and/or hypoglycemic activity which contain a substituted naphthyloxyalkylaminobenzoic acid or salt or ester thereof.

Naphthyloxyalkylaminobenzoic acids, salts and esters thereof

Novel para-[thienyl and furyl(alkyl or alkenyl)amino]-benzoic acids, esters, pharmaceutically acceptable salts and pharmaceutical compositions thereof and a method of lowering serum-lipid levels in mammals therewith.

Antilipidemic para-[thienyl and furyl (alkyl or alkenyl)amino]-benzoic

Antilipidemic para-[aryl(alkyl or alkenyl)amino]-benzoic acid derivatives

Aryloxyalkylaminobenzoic acids and esters as hypolipemic compounds.

Method of treating lipidemia with aryloxyalkylaminobenzoic acids and

Compounds of the formula: ##STR1## or pharmaceutically acceptable salts thereof wherein R.sub.4 is an unbranched or branched alkyl group C.sub.n H.sub.2n+1 wherein n is 8 to 19, having the ability to arrest the development of atheromatous lesions as well as to lower serum sterols and triglycerides in warm-blooded animals, are disclosed.

Polysubstituted-alkyl esters of 4-alkylaminobenzoic acids

Polysubstituted-alkyl esters of 4-alkylaminobenzoic acids having hypolipemic activity.

Growing community of inventors

Chester, NY, United States of America

Thomas G Miner